Acute myeloblastic leukaemia [aml] - what does this mean
Acute myeloblastic leukaemia (aml) is a type of cancer of the blood and bone marrow caused by an abnormal growth of myeloblasts, a type of white blood cell. it is a rapid-onset form of leukaemia that is characterised by the overproduction of immature white blood cells in the bone marrow.
What happens during the disease - acute myeloblastic leukaemia [aml]
Aml is a cancer of the bone marrow and blood caused by a genetic mutation which results in the abnormal production of immature myeloid cells that are unable to mature and function properly. this leads to an accumulation of these cells in the bone marrow and blood, resulting in an increased risk of infection and decreased production of healthy red blood cells, white blood cells, and platelets.
Treatment and Medical Assistance
Main goal: Treating Acute Myeloblastic Leukaemia (AML)
- Administering chemotherapy drugs
- Performing stem cell transplantation
- Administering targeted therapies
- Administering radiation therapy
- Prescribing supportive medications
- Performing surgery to remove the cancerous cells
24 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Acute myeloblastic leukaemia [aml] - Prevention
The best way to prevent acute myeloblastic leukaemia (aml) is to practice healthy lifestyle habits such as avoiding smoking, limiting exposure to environmental toxins, and eating a healthy diet rich in fruits and vegetables. additionally, regular physical activity and avoiding excessive alcohol consumption can help to reduce the risk of developing aml.